Additionally, metformin induces the autophagic flow by increasing the levels of LC3-II and decreasing the levels of p62, which leads to TRAIL-mediated apoptosis in TRAIL-resistant lung cancer cells (316). Here, SQSTM1 is linked to lung carcinoma.